FDA Approves Ixempra for Advanced Breast Cancer Patients

[News]

The U.S. Food and Drug Administration has approved Ixempra (ixabepilone), a new anti-cancer treatment, for use in patients with metastatic or locally advanced breast cancer who have not responded to certain other cancer drugs.

More... (http://www.news-medical.net/?id=31544)